Cochrane Abstracts
Anticoagulation for people receiving long‐term haemodialysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticoagulation for People Receiving Long‐term Haemodialysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440588/all/Anticoagulation_for_people_receiving_long‐term_haemodialysis.
Anticoagulation for people receiving long‐term haemodialysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440588/all/Anticoagulation_for_people_receiving_long‐term_haemodialysis. Accessed March 24, 2025.
Anticoagulation for people receiving long‐term haemodialysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440588/all/Anticoagulation_for_people_receiving_long‐term_haemodialysis
Anticoagulation for People Receiving Long‐term Haemodialysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440588/all/Anticoagulation_for_people_receiving_long‐term_haemodialysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticoagulation for people receiving long‐term haemodialysis
ID - 440588
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440588/all/Anticoagulation_for_people_receiving_long‐term_haemodialysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
